U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07677371) titled 'Position-Specific Lower Limb Performance and AI-Based Injury Risk Analysis in Young Male Bas... और पढ़ें
U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07676357) titled 'Safety, Tolerability, and Pharmacokinetics of Multiple-Dose RFUS-949 in Healthy Chinese Part... और पढ़ें
U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07675408) titled 'Validation of cueStim for Reduction of Freezing of Gait in Parkinson's Disease' on June 18. ... और पढ़ें
U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07677202) titled 'Large Language Models Versus Human Examiners for Grading Physiotherapy Clinical Cases' on Ju... और पढ़ें
U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07675499) titled 'Exercise and Intranasal Insulin in Type 2 Diabetes' on June 22. Brief Summary: About 6.5 mi... और पढ़ें
U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07676721) titled 'Shh Signaling in Brain AVMs: Novel Player & Therapeutic Target' on June 24. Brief Summary: ... और पढ़ें
Singapore, July 1 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherap... और पढ़ें
Singapore, July 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety... और पढ़ें
Singapore, July 1 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Mo... और पढ़ें
Singapore, July 1 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in... और पढ़ें